drugset / Trial / NCT00831051
Comparison of the Efficacy and Safety of Q8003 Versus Its Individual Components in Bunionectomy Patients
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This is a randomized, double-blind, multicenter, fixed dose factorial study of Q8003 12 mg/8 mg and Q8003 6 mg/4 mg versus its individual morphine sulfate and oxycodone hydrochloride components for the management of acute moderate to severe postoperative pain following bunionectomy surgery.
Timeline
- Start
- 2008-12
- Primary completion
- 2009-01
- Completion
- 2009-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Morphine | Other / unclassified | 6 mg | — |
| Comparator | Morphine | Other / unclassified | 12 mg | — |
| Comparator | Oxycodone | Other / unclassified | 4 mg | — |
| Comparator | Oxycodone | Other / unclassified | 8 mg | — |
| Subject | Q8003 | Unknown | — | — |
Indications
No indication recorded.